questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxidoreductases acting on CH-NH group donors
Oxidoreductases, (N-demethylating)
Oxidoreductases, (N-demethylating) : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxidoreductases, (N-demethylating) : Questions médicales les plus fréquentes",
"headline": "Oxidoreductases, (N-demethylating) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxidoreductases, (N-demethylating) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases acting on CH-NH group donors",
"url": "https://questionsmedicales.fr/mesh/D000587",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases acting on CH-NH group donors",
"code": {
"@type": "MedicalCode",
"code": "D000587",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aminopyrine N-demethylase",
"alternateName": "Aminopyrine N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D000633",
"about": {
"@type": "MedicalCondition",
"name": "Aminopyrine N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D000633",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydropteridine reductase",
"alternateName": "Dihydropteridine Reductase",
"url": "https://questionsmedicales.fr/mesh/D004093",
"about": {
"@type": "MedicalCondition",
"name": "Dihydropteridine reductase",
"code": {
"@type": "MedicalCode",
"code": "D004093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.361"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dimethylglycine dehydrogenase",
"alternateName": "Dimethylglycine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050893",
"about": {
"@type": "MedicalCondition",
"name": "Dimethylglycine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.369"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ethylmorphine-N-demethylase",
"alternateName": "Ethylmorphine-N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D005037",
"about": {
"@type": "MedicalCondition",
"name": "Ethylmorphine-N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D005037",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone Demethylases",
"alternateName": "Histone Demethylases",
"url": "https://questionsmedicales.fr/mesh/D056466",
"about": {
"@type": "MedicalCondition",
"name": "Histone Demethylases",
"code": {
"@type": "MedicalCode",
"code": "D056466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.475"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcosine dehydrogenase",
"alternateName": "Sarcosine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050892",
"about": {
"@type": "MedicalCondition",
"name": "Sarcosine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.550"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)",
"alternateName": "Oxidoreductases, N-Demethylating",
"code": {
"@type": "MedicalCode",
"code": "D010089",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christopher J Schofield",
"url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "Rajeev Ramanan",
"url": "https://questionsmedicales.fr/author/Rajeev%20Ramanan",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Sodiq O Waheed",
"url": "https://questionsmedicales.fr/author/Sodiq%20O%20Waheed",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Christo Z Christov",
"url": "https://questionsmedicales.fr/author/Christo%20Z%20Christov",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Samuel E Ross",
"url": "https://questionsmedicales.fr/author/Samuel%20E%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Selenium and breast cancer - An update of clinical and epidemiological data.",
"datePublished": "2022-11-13",
"url": "https://questionsmedicales.fr/article/36379313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.abb.2022.109465"
}
},
{
"@type": "ScholarlyArticle",
"name": "Erythrocyte and plasma selenium in children with acute inflammatory response.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36162157",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtemb.2022.127068"
}
},
{
"@type": "ScholarlyArticle",
"name": "Incorporation of Selenium Derived from Nanoparticles into Plant Proteins",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37530594",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsnano.3c03739"
}
},
{
"@type": "ScholarlyArticle",
"name": "Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37074160",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2bm02102a"
}
},
{
"@type": "ScholarlyArticle",
"name": "Proposal to Screen for Zinc and Selenium in Patients with IgA Deficiency.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37432290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu15092145"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxidoreductases acting on CH-NH group donors",
"item": "https://questionsmedicales.fr/mesh/D000587"
},
{
"@type": "ListItem",
"position": 6,
"name": "Oxidoreductases, (N-demethylating)",
"item": "https://questionsmedicales.fr/mesh/D010089"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxidoreductases, (N-demethylating) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxidoreductases, (N-demethylating)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxidoreductases, (N-demethylating)",
"description": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?\nQuels tests sont utilisés pour évaluer l'activité enzymatique ?\nQuels symptômes peuvent indiquer un dysfonctionnement enzymatique ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxidoreductases, (N-demethylating)",
"description": "Quels symptômes sont associés à une altération de la déméthylation ?\nLes troubles neurologiques peuvent-ils être liés à ces enzymes ?\nComment les effets secondaires des médicaments sont-ils liés ?\nLes symptômes varient-ils selon les individus ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxidoreductases, (N-demethylating)",
"description": "Comment prévenir les complications liées à la déméthylation ?\nY a-t-il des tests préventifs recommandés ?\nL'éducation des patients est-elle importante ?\nLes habitudes de vie peuvent-elles influencer la fonction enzymatique ?\nDes vaccinations peuvent-elles aider à prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxidoreductases, (N-demethylating)",
"description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nPeut-on utiliser des suppléments pour améliorer la fonction enzymatique ?\nLes modifications alimentaires peuvent-elles aider ?\nDes thérapies géniques sont-elles envisageables ?\nLes médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxidoreductases, (N-demethylating)",
"description": "Quelles complications peuvent survenir en cas de dysfonctionnement ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nY a-t-il des complications spécifiques aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxidoreductases, (N-demethylating)",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge joue-t-il un rôle dans le risque de dysfonctionnement ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?\nLe mode de vie influence-t-il le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Selenium&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité enzymatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des médicaments et des dosages enzymatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un dysfonctionnement enzymatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des réactions médicamenteuses inattendues peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains biomarqueurs peuvent indiquer une activité enzymatique altérée."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent mesurer les niveaux de métabolites spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une altération de la déméthylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, des vomissements et des réactions cutanées peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés à ces enzymes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison d'une accumulation de toxines."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires des médicaments sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une déméthylation inefficace peut entraîner des effets secondaires imprévus."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus aigus, comme des troubles de l'attention."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la déméthylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments connus pour interférer avec la déméthylation peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests préventifs recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les médicaments et leurs effets est crucial."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer la fonction enzymatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent améliorer la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des vaccinations peuvent-elles aider à prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui compliquent les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des ajustements médicamenteux peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des suppléments pour améliorer la fonction enzymatique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments comme les antioxydants peuvent aider à soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les modifications alimentaires peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir le métabolisme et la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisageables ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une option potentielle pour corriger des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ajuster les doses ou changer de médicament peut réduire les effets indésirables."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en cas de dysfonctionnement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des réactions médicamenteuses graves peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant des symptômes chroniques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière et des ajustements de traitement peuvent prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent entraîner des complications spécifiques, comme des allergies."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque de dysfonctionnement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge en raison de la diminution de la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles enzymatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines peut-elle augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications liées à la déméthylation."
}
}
]
}
]
}
There is an urgent need for new and improved therapeutic strategies in breast cancer, which is the most common malignancy affecting women in the United States and worldwide. Selenium (Se) is an essent...
Plasma selenium may not reflect selenium status in critically ill patients because it transiently decreases inversely with the magnitude of the systemic inflammatory response. The decision to suppleme...
In a prospective study of 109 critically ill children, plasma and erythrocyte selenium concentrations were evaluated on admission, and plasma selenoprotein P was evaluated on days 1, 2, and 3 of the I...
Erythrocyte selenium levels were not influenced by the magnitude of the inflammatory response or by the patient's clinical severity. Procalcitonin (β coefficient=-0.99; 95%CI: -1.64; -0.34, p = 0.003)...
Unlike plasma selenium, erythrocyte selenium does not change in children with an acute systemic inflammatory response and is associated with selenoprotein P concentrations. Erythrocyte selenium is pro...
Diets comprising selenium-deficient crops have been linked to immune disorders and cardiomyopathy. Selenium nanoparticles (SeNPs) have emerged as a promising nanoplatform for selenium-biofortified agr...
Selenium (Se) compounds are promising chemotherapeutics due to their ability to inhibit cancer cell activity...
The increase in life expectancy can be a consequence of the world's socioeconomic, sanitary and nutritional conditions. Some studies have demonstrated that individuals with a satisfactory diet variety...
to investigate the anthropometric, biochemical, and nutritional profiles and the status of zinc and selenium in patients with IgAD....
in this descriptive study, we screened 16 IgAD patients for anthropometric and dietary data, biochemical evaluation and determination of plasma and erythrocyte levels of zinc and selenium....
dietary intake of zinc and selenium was adequate in 75% and 86% of the patients, respectively. These results were consistent with the plasma levels (adequate levels of zinc in all patients and seleniu...
our results highlight the elevated prevalence of erythrocyte zinc and selenium deficiency in patients with IgAD, and the need for investigation of these micronutrients in their follow-up....
Selenium nanoparticles (SeNPs) can be biosynthesized by most Lactic acid bacteria thereby converting toxic sodium into SeNPs. However, few studies have reported the antimicrobial activity of biogenic ...
Selenium nanoparticles (SeNPs) are a unique type of nano-sized elemental selenium that have recently found wide application in biomedicine. It has been shown that the properties of SeNPs can be varied...
Selenium (Se) is an essential micronutrient for humans and a beneficial element for plants. However, high Se doses always exhibit hazardous effects. Recently, Se toxicity in plant-soil system has rece...
Reactive oxygen species (ROS) are important modulators of physiological signaling and play important roles in bone tissue regulation. Both reactive sulfur species (RSS) and reactive selenium species (...
Parkinson's disease (PD) is a neurodegenerative disease that is associated with oxidative stress. Due to the anti-inflammatory and antioxidant functions of Selenium (Se), this molecule may have neurop...
1-methyl-4-phenylpyridinium (MPP...
We identified 351 differentially expressed genes (DEGs) and 14 differentially expressed long non-coding RNAs (DELs) in MPP...
Our data suggests that the DEGs Txnrd1, Siglec1 and Klf2, and the DEL AABR07044454.1 which we hypothesize to function in cis on the target gene Cdkn1a, may modulate the underlying neurodegenerative pr...